Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Abstract Background Hyperemesis gravidarum (HG), excessive vomiting in pregnancy, occurs in 0.3–10.8% of pregnancies and is associated with maternal and fetal morbidity. Despite the existence of several off-label treatment options that have shown clinical effectiveness in managing HG symptoms, the v...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Pregnancy and Childbirth |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12884-024-07077-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|